Side-by-side comparison of AI visibility scores, market position, and capabilities
Fremont CA solar tracker market leader (NASDAQ: NXT) ~$3B revenue; TrueCapture AI sky-sensing software, $40M AI+Robotics acquisitions (OnSight/SenseHawk/Amir), Dr. Francesco Borrelli CARO competing with Array Technologies.
Nextracker Inc. is a Fremont, California-based solar tracker and software company — publicly traded on the NASDAQ (NASDAQ: NXT) — providing single-axis solar tracking systems, tracker control software, and AI-powered solar performance optimization for utility-scale solar power plants worldwide through approximately 1,200 employees and a global manufacturing and services network. Nextracker designs, manufactures, and supports the mechanical tracking systems (motorized mounting structures with GPS-connected control electronics) that orient solar panels toward the sun throughout each day — improving energy yield 20-25% compared to fixed-tilt mounting systems. Founded in 2013 and spun out from Flex Ltd. (NYSE: FLEX) as an independent public company in February 2023 (one of the largest cleantech IPOs of the decade), Nextracker is the market-leading solar tracker supplier globally with approximately 50%+ market share in the US utility solar market. CEO Dan Shugar — a solar industry pioneer with 35+ years of experience — leads Nextracker's expansion beyond tracker hardware into AI-powered intelligent solar field management. In 2025, Nextracker launched a new AI and Robotics business through $40+ million in technology acquisitions: OnSight Technology (autonomous robotic inspection drones for solar panel fault detection), SenseHawk's AI drone mapping IP (aerial solar field imaging and analysis), and Amir Robotics (waterless robotic panel cleaning using dry-brush technology) — with Dr. Francesco Borrelli (UC Berkeley robotics and autonomous systems professor) appointed Chief AI and Robotics Officer to lead the integrated AI and robotics platform.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.